Abnormal properties of red blood cells suggest a role in the pathophysiology of Gaucher disease

Blood

Volumn 121, Issue 3, 2013, Pages 546-555

  Franco, Melanie ^a,b,c   Collec, Emmanuel ^a,b,c   Connes, Philippe ^a,c,d   Van Den Akker, Emile ^e   De Villemeur, Thierry Billette ^f,g   Belmatoug, Nadia ^g,h   Von Lindern, Marieke ^e   Ameziane, Nejma ^a,b,c   Hermine, Olivier ^c,i   Colin, Yves ^a,b,c   Le Van Kim, Caroline ^a,b,c   Mignot, Cyril ^f,g  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Laboratoire d'Excellence   (France)

^d UNIVERSITÉ DES ANTILLES ET DE LA GUYANE   (France)

^e SANQUIN RESEARCH   (Netherlands)

^f ARMAND TROUSSEAU HOSPITAL   (France)

^g Lab de Biosociologie Anim et Hum   (France)

^h BEAUJON HOSPITAL   (France)

ⁱ HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOTRIOSIDASE; HEMOGLOBIN; IMMUNOGLOBULIN; LAMININ; LAMININ RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD RHEOLOGY; BLOOD VISCOSITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL STRUCTURE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ERYTHROCYTE; ERYTHROCYTE ADHESIVENESS; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; ERYTHROPOIESIS; FEMALE; GAUCHER DISEASE; GENE OVEREXPRESSION; GENOTYPE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; MALE; MEAN CORPUSCULAR VOLUME; MICROVASCULAR ENDOTHELIAL CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SHEAR STRESS; THROMBOCYTE COUNT;

EID: 84872576853     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-07-442467     Document Type: Article

References (45)

1. Cox TM, Schofield JP. Gaucher's disease: clinical features and natural history. Baillieres Clin Haematol. 1997;10(4):657-689. (Pubitemid 28022202)
2. Grabowski GA. Phenotype, diagnosis, and treatment of Gaucher's disease. Lancet. 2008;372(9645): 1263-1271.
3. StowensDW, Teitelbaum SL, KahnAJ, Barranger JA. Skeletal complications of Gaucher disease. Medicine (Baltimore). 1985;64(5):310-322. (Pubitemid 16224046)
4. Bembi B, Ciana G, Mengel E, Terk MR, Martini C, Wenstrup RJ. Bone complications in children with Gaucher disease. Br J Radiol. 2002;75(Suppl 1): A37-44.
5. Deegan PB, Pavlova E, Tindall J, et al. Osseous manifestations of adult Gaucher disease in the era of enzyme replacement therapy. Medicine (Baltimore). 2011;90(1):52-60.
6. Guggenbuhl P, Grosbois B, Chales G. Gaucher disease. Joint Bone Spine. 2008;75(2):116-124.
7. Rossi L, Zulian F, Stirnemann J, Billette de Villemur T, Belmatoug N. Bone involvement as presenting sign of pediatric-onset Gaucher disease. Joint Bone Spine. 2011;78(1):70-74.
8. Mikosch P. Miscellaneous noninflammatory musculoskeletal conditions. Gaucher disease and bone. Best Pract Res Clin Rheumatol. 2011; 25(5):665-681.
9. Wenstrup RJ, Roca-EspiauM,Weinreb NJ, Bembi B. Skeletal aspects of Gaucher disease: a review. Br J Radiol. 2002;75(Suppl 1):A2-12. (Pubitemid 34654095)
10. Lecourt S, Vanneaux V, Cras A, et al. Bone marrow microenvironment in an in vitro model of Gaucher disease: consequences of glucocerebrosidase deficiency. Stem Cells Dev. 2012; 21(2):239-248.
11. Mistry PK, Liu J, Yang M, et al. Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage. Proc Natl Acad Sci U S A. 2010;107(45):19473-19478.
12. Berger J, Lecourt S, Vanneaux V, et al. Glucocerebrosidase deficiency dramatically impairs human bone marrow haematopoiesis in an in vitro model of Gaucher disease. Br J Haematol. 2010; 150(1):93-101.
13. Erikson A, Forsberg H, Nilsson M, Astrom M, Mansson JE. Ten years' experience of enzyme infusion therapy of Norrbottnian (type 3) Gaucher disease. Acta Paediatr. 2006;95(3):312-317.
14. Nilsson O, Hakansson G, Dreborg S, Groth CG, Svennerholm L. Increased cerebroside concentration in plasma and erythrocytes in Gaucher disease: significant differences between type I and type III. Clin Genet. 1982;22(5):274-279. (Pubitemid 13209531)
15. Adar T, Ben-Ami R, Elstein D, et al. Aggregation of red blood cells in patients with Gaucher disease. Br J Haematol. 2006;134(4):432-437. (Pubitemid 44079557)
16. Bax BE, Richfield L, Bain MD, Mehta AB, Chalmers RA, Rampling MW. Haemorheology in Gaucher disease. Eur J Haematol. 2005;75(3): 252-258. (Pubitemid 41153107)
17. Bratosin D, Tissier JP, Lapillonne H, et al. A cytometric study of the red blood cells in Gaucher disease reveals their abnormal shape that may be involved in increased erythrophagocytosis. Cytometry B Clin Cytom. 2011;80(1):28-37.
18. Zimran A, Bashkin A, Elstein D, et al. Rheological determinants in patients with Gaucher disease and internal inflammation. Am J Hematol. 2004; 75(4):190-194. (Pubitemid 38451091)
19. van den Akker E, Satchwell TJ, Pellegrin S, Daniels G, Toye AM. The majority of the in vitro erythroid expansion potential resides in CD34(-) cells, outweighing the contribution of CD34(+) cells and significantly increasing the erythroblast yield from peripheral blood samples. Haematologica. 2010;95(9):1594-1598.
20. Lorincz M, Herzenberg LA, Diwu Z, Barranger JA, Kerr WG. Detection and isolation of gene-corrected cells in Gaucher disease via a fluorescenceactivated cell sorter assay for lysosomal glucocerebrosidase activity. Blood. 1997;89(9):3412-3420. (Pubitemid 27229829)
21. Wautier MP, El Nemer W, Gane P, et al. Increased adhesion to endothelial cells of erythrocytes from patients with polycythemia vera is mediated by laminin alpha5 chain and Lu/BCAM. Blood. 2007;110(3):894-901. (Pubitemid 47267426)
22. Kroviarski Y, El Nemer W, Gane P, et al. Direct interaction between the Lu/B-CAM adhesion glycoproteins and erythroid spectrin. Br J Haematol. 2004;126(2):255-264. (Pubitemid 38961946)
23. Bartolucci P, Chaar V, Picot J, et al. Decreased sickle red blood cell adhesion to laminin by hydroxyurea is associated with inhibition of Lu/ BCAM protein phosphorylation. Blood. 2010; 116(12):2152-2159.
24. Baskurt OK, Boynard M, Cokelet GC, et al. New guidelines for hemorheological laboratory techniques. Clin Hemorheol Microcirc. 2009;42(2):75-97.
25. Uyuklu M, Cengiz M, Ulker P, et al. Effects of storage duration and temperature of human blood on red cell deformability and aggregation. Clin Hemorheol Microcirc. 2009;41(4):269-278.
26. Hardeman MR, Dobbe JG, Ince C. The laserassisted optical rotational cell analyzer (LORCA) as red blood cell aggregometer. Clin Hemorheol Microcirc. 2001;25(1):1-11. (Pubitemid 34014671)
27. Cartron JP, Elion J. Erythroid adhesion molecules in sickle cell disease: effect of hydroxyurea. Transfus Clin Biol. 2008;15(1-2):39-50.
28. El Nemer W, Gane P, Colin Y, et al. The Lutheran blood group glycoproteins, the erythroid receptors for laminin, are adhesion molecules. J Biol Chem. 1998;273(27):16686-16693. (Pubitemid 28311691)
29. Berk DA, Hochmuth RM. Lateral mobility of integral proteins in red blood cell tethers. Biophys J. 1992;61(1):9-18.
30. Beutler E. Gaucher disease. Blood Rev. 1988; 2(1):59-70.
31. Stoltz JF, Lucius M. Viscoelasticity and thixotropy of human blood. Biorheology. 1981;18(3-6):453-473. (Pubitemid 11015408)
32. Baskurt OK, Meiselman HJ. RBCs aggregation: more important than RBCs adhesion to endothelial cells as a determinant of in vivo blood flow in health and disease. Microcirculation. 2008;15(7): 585-590.
33. Frenette PS. Sickle cell vasoocclusion: heterotypic, multicellular aggregations driven by leukocyte adhesion. Microcirculation. 2004;11(2):167-177. (Pubitemid 39619077)
34. Kato GJ, Hebbel RP, Steinberg MH, Gladwin MT. Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions. Am J Hematol. 2009;84(9):618-625.
35. Nash GB, Johnson CS, Meiselman HJ. Rheologic impairment of sickle RBCs induced by repetitive cycles of deoxygenation-reoxygenation. Blood. 1988;72(2):539-545.
36. Barabino GA, Platt MO, Kaul DK. Sickle cell biomechanics. Annu Rev Biomed Eng. 2010;12:345-367.
37. Kaul DK, Fabry ME. In vivo studies of sickle red blood cells. Microcirculation. 2004;11(2):153-165. (Pubitemid 39619076)
38. Almeida A, Roberts I. Bone involvement in sickle cell disease. Br J Haematol. 2005;129(4):482-490. (Pubitemid 40769897)
39. El Nemer W, Wautier MP, Rahuel C, et al. Endothelial Lu/BCAM glycoproteins are novel ligands for red blood cell alpha4beta1 integrin: role in adhesion of sickle red blood cells to endothelial cells. Blood. 2007;109(8):3544-3551. (Pubitemid 46572548)
40. Gauthier E, Rahuel C, Wautier MP, et al. Protein kinase A-dependent phosphorylation of Lutheran/ basal cell adhesion molecule glycoprotein regulates cell adhesion to laminin alpha5. J Biol Chem. 2005;280(34):30055-30062. (Pubitemid 41216181)
41. Inokuchi J, Momosaki K, Shimeno H, Nagamatsu A, Radin NS. Effects of D-threo-PDMP, an inhibitor of glucosylceramide synthetase, on expression of cell surface glycolipid antigen and binding to adhesive proteins by B16 melanoma cells. J Cell Physiol. 1989;141(3):573-583. (Pubitemid 20014305)
42. Groener JE, Poorthuis BJ, Kuiper S, Hollak CE, Aerts JM. Plasma glucosylceramide and ceramide in type 1 Gaucher disease patients: correlations with disease severity and response to therapeutic intervention. Biochim Biophys Acta. 2008;1781(1-2):72-78.
43. Meikle PJ, Whitfield PD, Rozaklis T, et al. Plasma lipids are altered in Gaucher disease: biochemical markers to evaluate therapeutic intervention. Blood Cells Mol Dis. 2008;40(3):420-427. (Pubitemid 351508448)
44. Boven LA, van Meurs M, Boot RG, et al. Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages. Am J Clin Pathol. 2004;122(3):359-369. (Pubitemid 39145540)
45. Moran MT, Schofield JP, Hayman AR, Shi GP, Young E, Cox TM. Pathologic gene expression in Gaucher disease: up-regulation of cysteine proteinases including osteoclastic cathepsin K. Blood. 2000;96(5):1969-1978. (Pubitemid 30662113)